Effect of Preoperative Bisphosphonate Treatment on Fracture Healing after Internal Fixation Treatment of Intertrochanteric Femoral Fractures

키워드

참고문헌 (30)

1. Ettinger B, "Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators", JAMA, 282, pp.637~645 (1999)
2. Watts NB, "Long-term use of bisphosphonates in osteoporosis", J Clin Endocrinol Metab, 95, pp.1555~1565 (2010)
3. Molvik H, "Bisphosphonates and their influence on fracture healing : a systematic review", Osteoporos Int, 26, pp.1251~1260 (2015)
4. Murakami H, "A possible mechanism of the specific action of bisphosphonates on osteoclasts : tiludronate preferentially affects polarized osteoclasts having ruffled borders", Bone, 17, pp.137~144 (1995)
5. Sato M, "Effects of bisphosphonates on isolated rat osteoclasts as examined by reflected light microscopy", J Bone Miner Res, 5, pp.31~40 (1990)
6. Colón-Emeric C, "Association between timing of zoledronic acid infusion and hip fracture healing", Osteoporos Int, 22, pp.2329~2336 (2011)
7. Kim TY, "Does early administration of bisphosphonate affect fracture healing in patients with intertrochanteric fractures?", J Bone Joint Surg Br, 94, pp.956~960 (2012)
8. 조윤제, "Does the Time of Postoperative Bisphosphonate Administration Affect the Bone Union in Osteoporotic Intertrochanteric Fracture of Femur?", Hip and Pelvis, 27(4), pp.258~264 (2015), 대한고관절학회[DOI]
9. Rozental TD, "Comparison of radiographic fracture healing in the distal radius for patients on and off bisphosphonate therapy", J Hand Surg Am, 34, pp.595~602 (2009)
10. Fogagnolo F, "Intramedullary fixation of pertrochanteric hip fractures with the short AO-ASIF proximal femoral nail", Arch Orthop Trauma Surg, 124, pp.31~37 (2004)
11. Corrales LA, "Variability in the assessment of fracture-healing in orthopaedic trauma studies", J Bone Joint Surg Am, 90, pp.1862~1868 (2008)
12. Koval KJ, "Ambulatory ability after hip fracture. A prospective study in geriatric patients", Clin Orthop Relat Res, (310), pp.150~159 (1995)
13. Harris ST, "Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. Vertebral Efficacy With Risedronate Therapy (VERT)Study Group", JAMA, 282, pp.1344~1352 (1999)
14. Lyles KW, "Zoledronic acid and clinical fractures and mortality after hip fracture", N Engl J Med, 357, pp.1799~1809 (2007)
15. 서중배, "Influence of Early Bisphosphonate Administration for Fracture Healing in Patients with Osteoporotic Proximal Humerus Fractures", Clinics in Orthopedic Surgery, 8(4), pp.437~443 (2016), 대한정형외과학회
16. Schell H, "Osteoclastic activity begins early and increases over the course of bone healing", Bone, 38, pp.547~554 (2006)
17. Einhorn TA, "The cell and molecular biology of fracture healing", Clin Orthop Relat Res, 355(Suppl), pp.S7~S21 (1998)
18. Li C, "Long-term effect of incadronate disodium(YM-175)on fracture healing of femoral shaft in growing rats", J Bone Miner Res, 16, pp.429~436 (2001)
19. Savaridas T, "Do bisphosphonates inhibit direct fracture healing?: a laboratory investigation using an animal model", Bone Joint J, 95-B, pp.1263~1268 (2013)
20. Peter CP, "Effect of alendronate on fracture healing and bone remodeling in dogs", J Orthop Res, 14, pp.74~79 (1996)
21. Li J, "Effect of bisphosphonate(incadronate)on fracture healing of long bones in rats", J Bone Miner Res, 14, pp.969~979 (1999)
22. Bauss F, "New model for simulation of fracture repair in fullgrown beagle dogs : model characterization and results from a long-term study with ibandronate", J Pharmacol Toxicol Methods, 50, pp.25~34 (2004)
23. Amanat N, "A single systemic dose of pamidronate improves bone mineral content and accelerates restoration of strength in a rat model of fracture repair", J Orthop Res, 23, pp.1029~1034 (2005)
24. Solomon DH, "The relation between bisphosphonate use and non-union of fractures of the humerus in older adults", Osteoporos Int, 20, pp.895~901 (2009)
25. Ha KY, "Does bisphosphonatebased anti-osteoporosis medication affect osteoporotic spinal fracture healing?", Osteoporos Int, 27, pp.483~488 (2016)
26. Russell RG, "Mechanisms of action of bisphosphonates : similarities and differences and their potential influence on clinical efficacy", Osteoporos Int, 19, pp.733~759 (2008)
27. Papapoulos SE, "Prolonged bisphosphonate release after treatment in children", N Engl J Med, 356, pp.1075~1076 (2007)
28. McClung MR, "Treatment of postmenopausal osteoporosis with delayedrelease risedronate 35 mg weekly for 2 years", Osteoporos Int, 24, pp.301~310 (2013)
29. Reid IR, "Intravenous zoledronic acid in postmenopausal women with low bone mineral density", N Engl J Med, 346, pp.653~661 (2002)
30. Xue D, "Do bisphosphonates affect bone healing? A meta-analysis of randomized controlled trials", J Orthop Surg Res, 9, pp.45~ (2014)

관련 논문AI추천